| 國立成功大學 |
2023 |
Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis
|
Chen, J.-Y.;Pan, H.-C.;Shiao, C.-C.;Chuang, M.-H.;See, C.Y.;Yeh, T.-H.;Yang, Yang Y.;Chu, W.-K.;Wu, V.-C. |
| 國立成功大學 |
2023 |
Improvement of composite kidney outcomes by AKI care bundles: a systematic review and meta-analysis
|
See, C.Y.;Pan, H.-C.;Chen, J.-Y.;Wu, C.-Y.;Liao, H.-W.;Huang, Y.-T.;Liu, J.-H.;Wu, V.-C.;Ostermann, M. |
| 臺大學術典藏 |
2022-09-20T06:50:04Z |
Reply to Mateu de Antonio et al. [5]
|
Wu V.-C.; Lin Y.-.H.; Tsai I.-J.; Wang Y.-T.; Wang C.-Y.; Wu K.-D.; HWANG, JUEY-JEN; Hsueh P.-R. |
| 臺大學術典藏 |
2022-09-20T06:50:03Z |
Levamisole-induced multifocal inflammatory leukoencephalopathy: Clinical characteristics, outcome, and impact of treatment in 31 patients
|
Wu V.-C.; Huang J.-W.; Lien H.-C.; Hsieh S.-T.; Liu H.-M.; Yang C.-C.; Lin Y.-H.; HWANG, JUEY-JEN; Wu K.-D. |
| 臺大學術典藏 |
2022-09-20T06:50:02Z |
High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency
|
Lin Y.-H.; Wu V.-C.; Tsai I.-J.; Ho Y.-L.; HWANG, JUEY-JEN; Tsau Y.-K.; Wu C.-Y.; Wu K.-D.; Hsueh P.-R. |
| 臺大學術典藏 |
2022-09-15T05:47:50Z |
FGF23 ameliorates ischemia-reperfusion induced acute kidney injury via modulation of endothelial progenitor cells: targeting SDF-1/CXCR4 signaling
|
Chang H.-M.; Peng K.-Y.; Chan C.-K.; Sun C.-Y.; Chen Y.-Y.; Chang H.-M.; Huang C.-L.; Liu P.-C.; Chen P.-Y.; Wang K.-C.; Wang W.-J.; Chen-Chi Wu; Lin Y.-F.; Lai T.-S.; Huang T.-M.; Young G.-H.; Lin S.-L.; Ostermann M.; Chu T.-S.; Chueh J.S.; Wu V.-C. |
| 臺大學術典藏 |
2022-09-15T03:00:18Z |
Endothelial dysfunction in primary aldosteronism
|
Chen Z.-W.; Tsai C.-H.; Pan C.-T.; Chou C.-H.; Liao C.-W.; Hung C.-S.; Wu V.-C.; Lin Y.-H.; Wu C.-H.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; YUNG-MING CHEN; Kuo C.-C.; Chang C.-C.; Liao S.-C.; Yen R.-F.; Wu K.-D.; TAIPAI Study Group |
| 臺大學術典藏 |
2022-09-15T03:00:17Z |
Subtypes of Histopathologically Classical Aldosterone-Producing Adenomas Yield Various Transcriptomic Signaling and Outcomes
|
Wu V.-C.; Peng K.-Y.; Kuo Y.-P.; Liu H.; Tan B.C.-M.; Lin Y.-H.; Lai T.-S.; YUNG-MING CHEN; Chueh J.S. |
| 臺大學術典藏 |
2022-09-15T03:00:17Z |
Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score–Matching Follow-Up Study With Tissue Doppler Imaging
|
Chang Y.-Y.; Liao C.-W.; Tsai C.-H.; Chen C.-W.; Pan C.-T.; Chen Z.-W.; Chen Y.-L.; Lin L.-C.; Chang Y.-R.; Wu V.-C.; Wu K.-D.; Hung C.-S.; Lin Y.-H.; Wu C.-H.; Chang H.-W.; Lian-Yu Lin M.D.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; YUNG-MING CHEN; Chang C.-C.; Liao S.-C.; Yen R.-F.; on behalf of the TAIPAI Study Group* |
| 臺大學術典藏 |
2022-09-15T03:00:16Z |
Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments
|
Wu V.-C.; Wang S.-M.; Huang K.-H.; Tsai Y.C.; Chan C.-K.; Yang S.-Y.; Lin L.-Y.; Chang C.-C.; Lu C.-C.; Lin Y.-H.; YUNG-MING CHEN; Chueh J.S. |
| 臺大學術典藏 |
2022-09-15T03:00:16Z |
Aldosterone-producing nodules and CYP11B1 signaling correlate in primary aldosteronism
|
Lin J.-H.; Peng K.-Y.; Kuo Y.-P.; Liu H.; Tan C.-M.B.; Lin Y.-F.; Chiu H.-W.; Lin Y.-H.; YUNG-MING CHEN; Chueh J.S.; Wu V.-C. |
| 臺大學術典藏 |
2022-09-15T03:00:15Z |
Predialysis serum lactate levels could predict dialysis withdrawal in Type 1 cardiorenal syndrome patients
|
Pan H.-C.; Huang T.-M.; Sun C.-Y.; Chou N.-K.; Tsao C.-H.; Yeh F.-Y.; Lai T.-S.; YUNG-MING CHEN; Wu V.-C. |
| 臺大學術典藏 |
2022-09-15T03:00:15Z |
Trends in the incidence and prevalence of end-stage kidney disease requiring dialysis in Taiwan: 2010–2018
|
Lai T.-S.; Hsu C.-C.; Lin M.-H.; Wu V.-C.; YUNG-MING CHEN |
| 臺大學術典藏 |
2022-09-15T03:00:14Z |
Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease
|
Wu V.-C.; Lin Y.-F.; Teng N.-C.; Yang S.-Y.; Chou N.-K.; Tsao C.-H.; YUNG-MING CHEN; Chueh J.S.; Chen L.; NSARF group |
| 臺大學術典藏 |
2022-09-15T03:00:14Z |
Distinct Subtyping of Successful Weaning from Acute Kidney Injury Requiring Renal Replacement Therapy by Consensus Clustering in Critically Ill Patients
|
Pan H.-C.; Sun C.-Y.; Huang T.T.-M.; Huang C.-T.; Tsao C.-H.; Lai C.-H.; YUNG-MING CHEN; Wu V.-C. |
| 臺大學術典藏 |
2022-09-06T07:43:41Z |
Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria
|
Tsai C.-W.; Wu V.-C.; Lin W.-C.; Huang J.-W.; MING-SHIANG WU |
| 臺大學術典藏 |
2022-09-06T02:43:03Z |
QT interval dispersion in dialysis patients
|
Wu V.-C.; LIAN-YU LIN; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:42:53Z |
131I-6β-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results
|
Yen R.-F.; Wu V.-C.; Liu K.-L.; Cheng M.-F.; Wu Y.-W.; Chueh S.-C.; Lin W.-C.; Wu K.-D.; Tzen K.-Y.; Lu C.-C.; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang F.-C.; Liao S.-C.; Hsieh B.-S. |
| 臺大學術典藏 |
2022-09-06T02:42:53Z |
Association of Kidney Function With Residual Hypertension After Treatment of Aldosterone-Producing Adenoma
|
Wu V.-C.; Chueh S.-C.; Chang H.-W.; LIAN-YU LIN; Liu K.-L.; Lin Y.-H.; Ho Y.-L.; Lin W.-C.; Wang S.-M.; Huang K.-H.; Hung K.-Y.; Kao T.-W.; Lin S.-L.; Yen R.-F.; Chen Y.-M.; Hsieh B.-S.; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:42:50Z |
Diagnosis of primary aldosteronism: Comparison of post-captopril active renin concentration and plasma renin activity
|
Wu V.-C.; Kuo C.-C.; Chang H.-W.; Tsai C.-T.; Lin C.-Y.; LIAN-YU LIN; Lin Y.-H.; Wang S.-M.; Huang K.-H.; Fang C.-C.; Ho Y.-L.; Liu K.-L.; Chang C.-C.; Chueh S.-C.; Lin S.-L.; Yen R.-F.; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:42:45Z |
Primary aldosteronism: Changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment
|
Wu V.-C.; Kuo C.-C.; Wang S.-M.; Liu K.-L.; Huang K.-H.; Lin Y.-H.; Chu T.-S.; Chang H.-W.; Lin C.-Y.; Tsai C.-T.; LIAN-YU LIN; Chueh S.-C.; Kao T.-W.; Chen Y.-M.; Chiang W.-C.; Tsai T.-J.; Ho Y.-L.; Lin S.-L.; Wang W.-J.; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:42:44Z |
Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy
|
Lin Y.-H.; Huang K.-H.; Lee J.-K.; Wang S.-M.; Yen R.-F.; Wu V.-C.; Chung S.-D.; Liu K.-L.; Chueh S.-C.; LIAN-YU LIN; Ho Y.-L.; Chen M.-F.; Wu K.-D.; Chang H.-W.; Hu F.-C.; Chen Y.-M.; Kuo C.-C.; Lu C.-C.; Chang F.-C.; Liao S.-C.; Lin W.-C.; Hsieh B.-S. |
| 臺大學術典藏 |
2022-09-06T02:42:42Z |
Kidney impairment in primary aldosteronism
|
Wu V.-C.; Yang S.-Y.; Lin J.-W.; Cheng B.-W.; Kuo C.-C.; Tsai C.-T.; Chu T.-S.; Huang K.-H.; Wang S.-M.; Lin Y.-H.; Chiang C.-K.; Chang H.-W.; Lin C.-Y.; LIAN-YU LIN; Chiu J.-S.; Hu F.-C.; Chueh S.-C.; Ho Y.-L.; Liu K.-L.; Lin S.-L.; Yen R.-F.; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:42:42Z |
The association of serum potassium level with left ventricular mass in patients with primary aldosteronism
|
Lin Y.-H.; Wang S.-M.; Wu V.-C.; Lee J.-K.; Kuo C.-C.; Yen R.-F.; Liu K.-L.; Huang K.-H.; Chueh S.-C.; Wang W.-J.; LIAN-YU LIN; Chien K.-L.; Ho Y.-L.; Chen M.-F.; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:42:41Z |
Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy
|
Lin Y.-H.; Lee H.-H.; Liu K.-L.; Lee J.-K.; Shih S.-R.; Chueh S.-C.; Lin W.-C.; Lin L.-C.; LIAN-YU LIN; Chung S.-D.; Wu V.-C.; Kuo C.-C.; Ho Y.-L.; Chen M.-F.; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:42:39Z |
Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma
|
Lin Y.-H.; LIAN-YU LIN; Chen A.; Wu X.-M.; Lee J.-K.; Su T.-C.; Wu V.-C.; Chueh S.-C.; Lin W.-C.; Lo M.-T.; Wang P.-C.; Ho Y.-L.; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:42:38Z |
Contrast-enhanced MRI index of diffuse myocardial fibrosis is increased in primary aldosteronism
|
Su M.-Y.M.; Wu V.-C.; Yu H.-Y.; Lin Y.-H.; Kuo C.-C.; Liu K.-L.; Wang S.-M.; Chueh S.-C.; LIAN-YU LIN; Wu K.-D.; Tseng W.-Y.I. |
| 臺大學術典藏 |
2022-09-06T02:42:33Z |
Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism
|
Wu C.-H.; Yang Y.-W.; Hu Y.-H.; Tsai Y.-C.; Kuo K.-L.; Lin Y.-H.; Hung S.-C.; Wu V.-C.; Wu K.-D.; Ho Y.-L.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang C.-C.; Chueh S.-C.; Lu C.-C.; Liao S.-C.; Yen R.-F. |
| 臺大學術典藏 |
2022-09-06T02:42:27Z |
Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy
|
Lu C.-C.; Wu V.-C.; Wu K.-D.; Liu K.-L.; Lin W.-C.; Cheng M.-F.; Tzen K.-Y.; Yen R.-F.; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chueh S.-C.; Chang F.-C.; Liao S.-C.; Hsieh B.-S. |
| 臺大學術典藏 |
2022-09-06T02:42:26Z |
Association between urine aldosterone and diastolic function in patients with primary aldosteronism and essential hypertension
|
Chang Y.-Y.; Lee H.-H.; Hung C.-S.; Wu X.-M.; Lee J.-K.; Wang S.-M.; Liao M.-T.; Chen Y.-H.; Wu V.-C.; Wu K.-D.; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Liu K.-L.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chueh S.-C.; Lu C.-C.; Chang F.-C.; Liao S.-C.; Yen R.-F.; Lin W.-C.; Hsieh B.-S.; the TAIPAI Study Group |
| 臺大學術典藏 |
2022-09-06T02:42:20Z |
The association between glomerular hyperfiltration and left ventricular structure and function in patients with primary aldosteronism
|
Liao M.-T.; Wu X.-M.; Chang C.-C.; Liao C.-W.; Chen Y.-H.; Lu C.-C.; Lin Y.-T.; Chang Y.-Y.; Hung C.-S.; Lin L.-C.; Lai C.-L.; LIAN-YU LIN; Wu V.-C.; Ho Y.-L.; Wu K.-D.; Lin Y.-H.; TAIPAI Study Group |
| 臺大學術典藏 |
2022-09-06T02:42:19Z |
Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population
|
Wu V.-C.; Huang K.-H.; Peng K.-Y.; Tsai Y.-C.; Wu C.-H.; Wang S.-M.; Yang S.-Y.; LIAN-YU LIN; Chang C.-C.; Lin Y.-H.; Lin S.-L.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:42:17Z |
The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old
|
Kuo C.-C.; Balakrishnan P.; Hsein Y.-C.; Wu V.-C.; Chueh S.-C.J.; Chen Y.-M.; Wu K.-D.; Wang M.-J.; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chang C.-C.; Lu C.-C.; Liao S.-C.; Yen R.-F.; Lin W.-C.; Hsieh B.-S.; TAIPAI group |
| 臺大學術典藏 |
2022-09-06T02:42:14Z |
Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: Prospective study of 102 patients
|
Liao C.-W.; LIAN-YU LIN; Hung C.-S.; Lin Y.-T.; Chang Y.-Y.; Wang S.-M.; Wu V.-C.; Wu K.-D.; Ho Y.-L.; Satoh F.; Lin Y.-H. |
| 臺大學術典藏 |
2022-09-06T02:42:13Z |
Heart rhythm complexity impairment in patients undergoing peritoneal dialysis
|
Lin Y.-H.; Lin C.; Ho Y.-H.; Wu V.-C.; Lo M.-T.; Hung K.-Y.; Liu L.-Y.D.; LIAN-YU LIN; Huang J.-W.; Peng C.-K. |
| 臺大學術典藏 |
2022-09-06T02:42:11Z |
Long term outcome of Aldosteronism after target treatments
|
Wu V.-C.; Wang S.-M.; Chang C.-H.; Hu Y.-H.; LIAN-YU LIN; Lin Y.-H.; Chueh S.-C.J.; Chen L.; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:42:08Z |
Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy
|
Chang C.-H.; Hu Y.-H.; Tsai Y.-C.; Wu C.-H.; Wang S.-M.; LIAN-YU LIN; Lin Y.-H.; Satoh F.; Wu K.-D.; Wu V.-C. |
| 臺大學術典藏 |
2022-09-06T02:42:06Z |
Corrigendum: Long term outcome of Aldosteronism after target treatments
|
Wu V.-C.; Wang S.-M.; Chang C.-H.; Hu Y.-H.; LIAN-YU LIN; Lin Y.-H.; Chueh S.-C.J.; Chen L.; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:42:04Z |
Case detection and diagnosis of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Wu V.-C.; Hu Y.-H.; Er L.K.; Yen R.-F.; Chang C.-H.; Chang Y.-L.; Lu C.-C.; Chang C.-C.; Lin J.-H.; Lin Y.-H.; Wang T.-D.; Wang C.-Y.; Tu S.T.; Jeff Chueh S.-C.; Tseng F.-Y.; Wu K.-D.; Wang W.-J.; Wu C.-H.; Ho Y.-L.; LIAN-YU LIN; Hu Y.-H.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Liao S.-C.; TAIPAI group |
| 臺大學術典藏 |
2022-09-06T02:41:59Z |
Primary aldosteronism and cerebrovascular diseases
|
Chen Z.-W.; Hung C.-S.; Wu V.-C.; Lin Y.-H.; Wu C.-H.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Chang C.-C.; Liao S.-C.; Yen R.-F.; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:41:59Z |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Yen R.-F. |
| 臺大學術典藏 |
2022-09-06T02:41:58Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2022-09-06T02:41:55Z |
Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism
|
Chen Y.-Y.; Lin Y.-H.H.; Huang W.-C.; Chueh E.; Chen L.; Yang S.-Y.; Lin P.-C.; LIAN-YU LIN; Lin Y.-H.; Wu V.-C.; Chu T.-S.; Wu K.D. |
| 臺大學術典藏 |
2022-09-06T02:41:52Z |
Endothelial dysfunction in primary aldosteronism
|
Chen Z.-W.; Tsai C.-H.; Pan C.-T.; Chou C.-H.; Liao C.-W.; Hung C.-S.; Wu V.-C.; Lin Y.-H.; Wu C.-H.; Ho Y.-L.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang C.-C.; Liao S.-C.; Yen R.-F.; Wu K.-D.; TAIPAI Study Group |
| 臺大學術典藏 |
2022-09-06T02:41:52Z |
Efficacy of Antiplatelet Agent Usage for Primary and Secondary Prevention in Dialysis Patients: a Nationwide Data Survey and Propensity Analysis
|
Chen Z.-W.; Wu C.-K.; Yang Y.-H.; Huang J.-W.; Wu V.-C.; Lee J.-K.; Chen P.-C.; Lin Y.-H.; LIAN-YU LIN |
| 臺大學術典藏 |
2022-09-06T02:41:50Z |
Transtubular potassium gradient predicts kidney function impairment after adrenalectomy in primary aldosteronism
|
Liao H.-W.; Wang S.-M.; Chan C.-K.; Lin Y.-H.; Lin P.-C.; Ho C.-H.; Liu Y.-C.; Chueh J.S.; Wu V.-C.; Lai T.-S.; Yang S.-Y.; Liu K.-L.; Chang C.-C.; Lee B.-C.; Huang K.-H.; LIAN-YU LIN; Liao S.-C.; Yen R.-F.; Lu C.-C.; Er L.-K.; Hu Y.-H.; Chang C.-H.; Wu C.-H.; Tsai Y.-C.; Chueh S.-C.J.; Huang W.-C.; Chen Y.-Y.; Wu K.-D. |
| 臺大學術典藏 |
2022-09-06T02:41:38Z |
Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection
|
Chan C.-K.; Chang Y.-Y.; Tsai Y.-C.; Chen Z.-W.; Wu C.-Y.; Huang W.-C.; Yen I.-W.; Wu K.-H.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Hu Y.-H.; Er L.K.; Chang C.-H.; Tsai Y.-C.; Yu C.-C.; LIAN-YU LIN; Hu F.-C.; Chang C.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Jeff Chueh S.-C.; Liao S.-C.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI Study Group |
| 臺大學術典藏 |
2022-09-06T02:41:34Z |
Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments
|
Wu V.-C.; Wang S.-M.; Huang K.-H.; Tsai Y.C.; Chan C.-K.; Yang S.-Y.; LIAN-YU LIN; Chang C.-C.; Lu C.-C.; Lin Y.-H.; Chen Y.-M.; Chueh J.S. |
| 臺大學術典藏 |
2022-08-09T05:30:40Z |
Diabetes mellitus is associated with worse baseline and less post-treatment recovery of arterial stiffness in patients with primary aldosteronism
|
Tsai C.-H.; Wu X.-M.; CHE-WEI LIAO; Chen Z.-W.; Pan C.-T.; Chang Y.-Y.; Lee B.-C.; Chiu Y.-W.; Lai T.-S.; Wu V.-C.; Hung C.-S.; Lin Y.-H. |
| 臺大學術典藏 |
2022-08-09T05:30:39Z |
Aldosterone Suppresses Endothelial Mitochondria through Mineralocorticoid Receptor/Mitochondrial Reactive Oxygen Species Pathway
|
Peng S.-Y.; Tsai C.-H.; Wu X.-M.; Huang H.-H.; Chen Z.-W.; Lee B.-C.; Chang Y.-Y.; Pan C.-T.; Wu V.-C.; Chou C.-H.; Hung C.-S.; CHE-WEI LIAO; Lin Y.-H. |
